Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Total revenue	$ 7,145	$ 5,353
Operating expenses
Selling, general and administrative	12,815	10,620
Research and development	8,788	13,593
Cost of goods sold	760	652
Total operating expenses	22,363	24,865
Loss from operations	(15,218)	(19,512)
Other income (expense)
Gain on sale of business	87,443	0
Foreign exchange loss	0	(1)
Interest income	791	1,282
Interest expense	0	(58)
Total other income (expense), net	88,234	1,223
Net income (loss)	73,016	(18,289)
Other comprehensive income (loss):
Unrealized loss on investments, net of tax	(15)	(35)
Comprehensive income (loss)	$ 73,001	$ (18,324)
Net income (loss) per share:
Basic (in dollars per share)	$ 1.84	$ (0.68)
Diluted (in dollars per share)	$ 1.83	$ (0.68)
Weighted average shares outstanding:
Basic (in shares)	39,640,826	26,980,698
Diluted (in shares)	39,932,539	26,980,698
Product sales, net
Total revenue	$ 7,145	$ 5,353